Shoulder joint Rotator Cuff Tear Arthropathy
Conditions
Interventions
This is a prospective, controlled, randomized study. Participants will be patients over 50 years of age with advanced shoulder osteoarthritis, refractory to conservative treatment, and with an indicat
Sponsors
Hospital Universitário Pedro Ernesto da Universidade do Estado do Rio de Janeiro
Hospital Universitário Pedro Ernesto da Universidade do Estado do Rio de Janeiro
Eligibility
Age
50 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients of both genders; aged over 50 years; with symptomatic glenohumeral osteoarthritis that has not improved with appropriate conventional conservative treatment and with an indication for shoulder arthroplasty; with glenohumeral osteoarthritis grades 1 to 5 according to the Hamada classification.
Exclusion criteria
Exclusion criteria: Failure to sign the Informed Consent Form; psychiatric and/or cognitive disorders that preclude assessment and follow-up; coagulopathies; malignant neoplasm within the last five years; orthobiologic procedures in the same joint within the past 6 months; stroke or acute myocardial infarction within the last 3 months; intolerance or allergy to local anesthetic.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We expect to observe an improvement in shoulder function after bone marrow aspirate injection, as measured by pain and functional scores (Visual Analog Scale, Short Form-12, Shoulder Pain and Disability Index, and the American Shoulder and Elbow Surgeons Shoulder Score) | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in shoulder pain after bone marrow aspirate injection, as measured by the Visual Analog Scale for pain. | — |
Countries
BR
Contacts
Public ContactAndré Luiz de Campos Pessoa
Hospital Universitário Pedro Ernesto
Outcome results
None listed